Suchergebnisse - "Gooding, Sarah"

PubPharm (60)

1

Human bone marrow organoids for disease modelling, discovery and validation of therapeutic targets in hematological malignancies

enthalten in: bioRxiv.org | 2024

von Khan, A. | Colombo, M. | Reyat, J. | +15

2

Deletion of arrestin-3 does not improve compulsive drug-seeking behavior in a longitudinal paradigm of oral morphine self-administration

enthalten in: bioRxiv.org | 2024

von Gooding, S. | Felth, L. | Foxall, R. | +9

3

Deletion of arrestin-3 does not improve compulsive drug-seeking behavior in a longitudinal paradigm of oral morphine self-administration

enthalten in: bioRxiv : the preprint server for biology | 2024

von Gooding, S. | Felth, L. | Foxall, R. | +9

4

Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination

enthalten in: European journal of haematology | 2024

von Twumasi, C. | Moore, S. | Sadler, R. | +20

5

A Balancing Act : Learning from the Past to Build a Future-Focused Opioid Strategy

enthalten in: Annual review of physiology | 2024

von Gooding, S. | Whistler, J.

6

Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma

enthalten in: Haematologica | 2024

von Agarwal, G. | Moore, S. | Sadler, R. | +21

7

Determinants of durable humoral and T cell immunity in myeloma patients following COVID‐19 vaccination

enthalten in: European Journal of Haematology | 2024

von Twumasi, C. | Moore, S. | Sadler, R. | +20

8

Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma

enthalten in: Blood | 2023

von Ansari-Pour, N. | Samur, M. | Flynt, E. | +10

CommentIn: Blood. 2023 Feb 9;141(6):560-561. - PMID 36757732

9

Correction : Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma

enthalten in: Blood cancer journal | 2023

von Kurata, K. | James-Bott, A. | Tye, M. | +26

ErratumFor: Blood Cancer J. 2023 Jan 12;13(1):12. - PMID 36631435

10

Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies

enthalten in: Cancer discovery | 2023

von Khan, A. | Rodriguez-Romera, A. | Reyat, J. | +24

CommentIn: Cancer Discov. 2023 Feb 6;13(2):263-265. - PMID 36744319

1
2
3
4
5
6
Nächster »
[6]